NCT00432731View on ClinicalTrials.gov

Safety Study of a Refrigerator-stable Formulation of VARIVAX®

PHASE4CompletedINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions

VaricellaMeaslesMumpsRubella

Interventions

BIOLOGICAL

VARIVAX®

BIOLOGICAL

M-M-RTM II

Trial Locations (25)

Unknown

Amboise

Ancenis

Betton

Châteaubriant

Courbevoie

Essey-lès-Nancy

Floirac

Fougères

Garches

Gradignan

Issy-les-Moulineaux

Joué-les-Tours

Libourne

Lingolsheim

Mérignac

Nancy

Paris

Rueil-Malmaison

Strasbourg

Suresnes

Tours

Tresses

Vandœuvre-lès-Nancy

Villers-lès-Nancy

Ragusa

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00432731 - Safety Study of a Refrigerator-stable Formulation of VARIVAX® | Biotech Hunter | Biotech Hunter